VTAK (Catheter Precision, Inc.) Stock Analysis - Analyst Ratings

Catheter Precision, Inc. (VTAK) is a publicly traded Healthcare sector company. As of May 21, 2026, VTAK trades at $0.80 with a market cap of $2.23M and a P/E ratio of -0.05. VTAK moved -3.83% today. Year to date, VTAK is -61.62%; over the trailing twelve months it is -85.28%. Its 52-week range spans $0.75 to $33.06. Rallies surfaces VTAK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate VTAK?

The average price target is $0.00.

VTAK Key Metrics

Key financial metrics for VTAK
MetricValue
Price$0.80
Market Cap$2.23M
P/E Ratio-0.05
EPS$-15.90
Dividend Yield0.00%
52-Week High$33.06
52-Week Low$0.75
Volume394
Avg Volume0
Revenue (TTM)$819.00K
Net Income$-17.70M
Gross Margin92.31%

VTAK Analyst Consensus

VTAK analyst coverage data. Average price target: $0.00.

Latest VTAK News

Recent VTAK Insider Trades

  • COLOMBATTO MARTIN J sold 3 (~$1.201) on Jan 29, 2025.
  • JENKINS DAVID A bought 9.53K (~$5.69K) on Jan 23, 2024.
  • JENKINS DAVID A bought 9.53K (~$4.09K) on Jan 22, 2024.

Common questions about VTAK

What do analysts rate VTAK?
The average price target is $0.00.
Does Rallies show VTAK price targets?
Yes. Rallies tracks VTAK analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is VTAK research on Rallies investment advice?
No. Rallies provides research, data, and educational context for VTAK. It does not provide personalized investment advice.
VTAK

VTAK